Improved (n = 31) | Non-improved (n = 73) | P value | |||
---|---|---|---|---|---|
Median | IQR | Median | IQR | ||
Age | 62 | 51–69 | 70 | 63–77.5 | 0.003 |
Sex (males/females) | 20/11 | 55/19 | 0.262 | ||
BMI (kg/m2) | 23.8 | 19.8–25.1 | 23.3 | 20.3–26.1 | 0.934 |
Disease duration (mo) | 7 | 2–39 | 19 | 6.3–39.5 | 0.0275 |
Hospitalization period | 14 | 13–18 | 14 | 13–16 | 0.742 |
ΔHand grip strength (kg) | 2.5 | − 2.4–.5 | 0 | − 3.8–1.9 | 0.001 |
ΔSTEF | 5 | 1–11 | 1 | − 1.5–4 | 0.0007 |
Δ10m walking test (s) | 0 | − 0.9–0 | 0 | − 0.5–0.4 | 0.487 |
ΔTUG (s) | 0 | − 0.6–0 | 0 | − 0.7–0.3 | 0.486 |
ΔOne-leg standing test (s) | 0 | 0–9.3 | 0 | 0–1.5 | 0.178 |